GlassScriptPhysician profile
Ronald K Watanabe
NPI 1942200316
$1,846.80
in general payments reported to CMS, 2019-2025
14 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $170 · 2021: $18.44 · 2022: $326 · 2023: $541 · 2024: $663 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983 · Gift: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $983.26 |
| Gift | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionary Optics LLC | $350.00 | 2023 | |
| Dompe US, INC. | $262.31 | 2024 | Oxervate |
| Bausch & Lomb Americas INC. | $229.41 | 2023-2025 | Infuse, Infuse Multifocal |
| Johnson & Johnson Vision Care, INC. | $213.38 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $205.82 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $168.56 | 2020-2021 | |
| Coopervision INC. | $162.75 | 2022-2024 | Myday Contact Lens, Clariti Contact Lens, Paragon Crt |
| Allergan, INC. | $107.91 | 2022 | |
| Alcon Vision LLC | $70.30 | 2024-2025 | Dailies Total1, Precision7, Total30 |
| Abbvie INC. | $19.78 | 2022 | |
| Oyster Point Pharma, INC. | $19.78 | 2023 | Tyrvaya |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $17.40 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Watanabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.